These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup. Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452 [TBL] [Abstract][Full Text] [Related]
43. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants. Weigang S; Fuchs J; Zimmer G; Schnepf D; Kern L; Beer J; Luxenburger H; Ankerhold J; Falcone V; Kemming J; Hofmann M; Thimme R; Neumann-Haefelin C; Ulferts S; Grosse R; Hornuss D; Tanriver Y; Rieg S; Wagner D; Huzly D; Schwemmle M; Panning M; Kochs G Nat Commun; 2021 Nov; 12(1):6405. PubMed ID: 34737266 [TBL] [Abstract][Full Text] [Related]
44. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022. Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547 [TBL] [Abstract][Full Text] [Related]
45. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries. Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568 [TBL] [Abstract][Full Text] [Related]
46. Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab. Van der Moeren N; Selhorst P; Ha M; Heireman L; Van Gaal PJ; Breems D; Meysman P; Laukens K; Verstrepen W; Van Gasse N; Ogunjimi B; Arien KK; Naesens R Viruses; 2022 Apr; 14(4):. PubMed ID: 35458482 [TBL] [Abstract][Full Text] [Related]
47. SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant. Sentis C; Billaud G; Bal A; Frobert E; Bouscambert M; Destras G; Josset L; Lina B; Morfin F; Gaymard A; The Covid-Diagnosis Hcl Study Group Viruses; 2022 Apr; 14(5):. PubMed ID: 35632661 [TBL] [Abstract][Full Text] [Related]
48. Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts. Nevejan L; Ombelet S; Laenen L; Keyaerts E; Demuyser T; Seyler L; Soetens O; Van Nedervelde E; Naesens R; Geysels D; Verstrepen W; Cattoir L; Martens S; Michel C; Mathieu E; Reynders M; Evenepoel A; Hellemans J; Vanhee M; Magerman K; Maes J; Matheeussen V; Boogaerts H; Lagrou K; Cuypers L; André E Viruses; 2022 Dec; 14(12):. PubMed ID: 36560741 [TBL] [Abstract][Full Text] [Related]
49. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection. Tarhini H; Recoing A; Bridier-Nahmias A; Rahi M; Lambert C; Martres P; Lucet JC; Rioux C; Bouzid D; Lebourgeois S; Descamps D; Yazdanpanah Y; Le Hingrat Q; Lescure FX; Visseaux B J Infect Dis; 2021 May; 223(9):1522-1527. PubMed ID: 33556961 [TBL] [Abstract][Full Text] [Related]
50. Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus. Zhao J; Liao X; Wang H; Wei L; Xing M; Liu L; Zhang Z Clin Infect Dis; 2020 Nov; 71(16):2233-2235. PubMed ID: 32270178 [TBL] [Abstract][Full Text] [Related]
51. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906 [TBL] [Abstract][Full Text] [Related]
52. Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection. Davies J; Gibani MM; Portone G; McGregor A J Infect; 2022 Jul; 85(1):e18-e20. PubMed ID: 35427720 [No Abstract] [Full Text] [Related]
53. Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Tseng HF; Ackerson BK; Luo Y; Sy LS; Talarico CA; Tian Y; Bruxvoort KJ; Tubert JE; Florea A; Ku JH; Lee GS; Choi SK; Takhar HS; Aragones M; Qian L Nat Med; 2022 May; 28(5):1063-1071. PubMed ID: 35189624 [TBL] [Abstract][Full Text] [Related]
54. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant. Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269 [TBL] [Abstract][Full Text] [Related]
55. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida. Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302 [TBL] [Abstract][Full Text] [Related]
60. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA. Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]